ライフサイエンスコーパス: steroid withdrawal

1 , develop delayed graft function, or undergo steroid withdrawal.

2 ant in kidney transplant recipients on rapid steroid withdrawal.

3 y glucocorticoid taper in a regimen of early steroid withdrawal.

4 w signature remained stable before and after steroid withdrawal.

5 lta receptors, which are increased following steroid withdrawal.

6 its accompanying risk of acute rejection on steroid withdrawal.

7 mained viable and resumed proliferation upon steroid withdrawal.

8 dices were also observed in association with steroid withdrawal.

9 Of the 124 patients analyzed for steroid withdrawal, 1-, 2-, and 4-year patient survival

10 Relapses occurred in 53% after steroid withdrawal; 44% relapsed after surgery and were

11 combination maintenance, both regimens using steroid withdrawal after 7 days.

12 For noninferiority, rituximab had to permit steroid withdrawal and maintain 3-month proteinuria (mg/

13 of SD-rATG induction in the context of early steroid withdrawal and tacrolimus minimization or withdr

14 rnate-day doses (1.5 mg/kg/dose), with early steroid withdrawal and tacrolimus or sirolimus maintenan

15 ovement toward minimal immunosuppression and steroid withdrawal and the development of safer and more

16 olled study evaluated safety and efficacy of steroid withdrawal at 2 days in kidney recipients monito

17 tion, tacrolimus, mycophenolate mofetil, and steroid withdrawal by day 5 after transplantation in our

18 conclude that renal transplant recipients on steroid withdrawal by the end of week 1 are not at highe

19 These data show for the first time that steroid withdrawal can be safely accomplished in pancrea

20 Steroid withdrawal causes rapid rebound of inflammation,

21 2 in QbG10-treated patients (n = 33) despite steroid withdrawal, compared with deteriorations observe

22 In 42 (86%) of 49 patients allocated to steroid withdrawal, complete steroid withdrawal was achi

23 ant in kidney transplant recipients on rapid steroid withdrawal does not decrease the progression of

24 Relapses are common after steroid withdrawal, especially with proximal strictures.

25 Steroid withdrawal from patients taking prednisone for t

26 diagnosed in 21% in control group and 4% in steroid withdrawal group (P<0.01).

27 y recipients were studied; 150 in second-day steroid withdrawal group and 150 in steroid treated grou

28 e in the first year in 25 (53%) of 47 in the steroid withdrawal group compared with 9 (18%) of 50 in

29 (27), 151 (36), and 150 (36) mumol/L in the steroid withdrawal group versus 138 (34), 140 (51), and

30 Of 22 patients in the steroid withdrawal group, 10 were DSR+ and 12 were DSR-

31 diagnosed in 14% in control group and 16% in steroid withdrawal group.

32 nd 1.8+/-0.9 mg/dl and 61+/-10 mls/minute in steroid withdrawal group.

33 NODM was significantly less in steroid withdrawal group.

34 as 89% and 79% in control and 91% and 78% in steroid withdrawal group.

35 l cholesterol declined about 1 mmol/L in the steroid withdrawal group.

36 of patients deemed not to be candidates for steroid withdrawal (group 2, n=15).

37 Two-day steroid withdrawal in kidney transplant recipients did n

38 of this analysis was to assess the safety of steroid withdrawal in our pediatric renal transplant rec

39 The results of steroid withdrawal in pancreas transplant recipients und

40 These data suggest that steroid withdrawal in pediatric renal transplant patient

41 Past attempts at steroid withdrawal in pediatric renal transplantation ha

42 pression were similar, except for more early steroid withdrawal in the high-dose group.

43 ithout evidence of toxicity while permitting steroid withdrawal in the majority of patients.

44 active antibody, delayed graft function, and steroid withdrawal; in these groups, cytolytic induction

45 Steroid withdrawal is associated with excellent patient

46 Late steroid withdrawal is feasible in most patients with sta

47 posttransplant in kidney recipients on rapid steroid withdrawal is poorly tolerated and does not impr

48 Two-day steroid withdrawal is safe and beneficial in kidney tran

49 It has also been reported that following steroid withdrawal, KS lesions often undergo partial or

50 Steroid withdrawal may be associated with long-term dete

51 DSR before steroid withdrawal may identify a subset of transplant p

52 ved in 58 (47%) patients with a mean time to steroid withdrawal of 15.2+/-8 months (range 4 to 40 mon

53 Steroid withdrawal patients showed a further rise in mea

54 sts even with successful transplantation and steroid withdrawal protocols.

55 n in pancreas recipients, there was a higher steroid withdrawal rate (p = 0.02), fewer rejection epis

56 An early steroid withdrawal regimen with antithymocyte globulin i

57 ents treated with steroids for relapse after steroid withdrawal responded; 7 patients on additional i

58 r risk have motivated increasing interest in steroid withdrawal (SW).

59 tained, being more evident immediately after steroid withdrawal than at one year.

60 Incorporating a controlled steroid withdrawal, the effects on patient-reported (day

61 Twenty-four hours after steroid withdrawal, the time constant for decay of GABAA

62 tration has risen from 1.28+/-.0.37 prior to steroid withdrawal to 1.64+0.54 at last follow-up (P=0.0

63 t study, we have characterized properties of steroid withdrawal using a pseudopregnant rat model.

64 1.1 years (range 1.0 to 4.8 years), complete steroid withdrawal was achieved in 58 (47%) patients wit

65 ts allocated to steroid withdrawal, complete steroid withdrawal was achieved.

66 Steroid withdrawal was associated with significant reduc

67 A randomised controlled trial of steroid withdrawal was conducted among renal transplant

68 Complete steroid withdrawal was possible in 31 (65%) of the 48 pa

69 Other changes associated with steroid withdrawal were reductions in white cell count a